Department of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, 450008, China.
Department of Pharmacology, Henan University of Chinese Medicine, Zhengzhou, 450008, China; International Center for TCM Immune-pharmacology, Henan University of Chinese Medicine, Zhengzhou, 450008, China.
J Ethnopharmacol. 2019 Jun 28;238:111884. doi: 10.1016/j.jep.2019.111884. Epub 2019 Apr 14.
Desertliving Cistanche herb was first recorded in "Shen Nong'Herbal Classic" and listed as the top grade herbal medicine in it. Phenylethanoid glycosides are indicative components for identification and content determination of Desertliving Cistanche herb in Chinese pharmacopoeia, which is also one of the main active components. In this research, we explored the mechanism of phenylethanoid glycosides of Desertliving Cistanche herb to the perimenopausal model rats.
The purpose of this study is to research the effects of phenylethanoid glycosides of Desertliving Cistanche herb (PGC) on the neuroendocrine-immune function of perimenopausal syndrome by perimenopausal model rats.
Wistar female rats were selected. The left ovaries for all rats except in the blank control group(BC) were removed, and the right ovaries were removed in 80%. The vaginal smear showed irregular estrous cycle changes for the perimenopausal model rats. And the perimenopausal model rats were gavaged Gengnian'an, Phenylethanoid Glycosides of Desertliving Cistanche herb high, medium, low suspension which is 450mg/(kg day), 133.33mg/(kg day), 66.67mg/(kg day), 33.33mg/(kg day); the group of BC and model group (MC)were given distilled water in the same volume as the drugs group for 30 consecutive days. Horizontal-vertical exercise scores were measured at 29 days of dosing. After the last administration, the blood was taken from the abdominal aorta, and levels of E, LH, FSH, GnRH, BGP in serum, and the levels β-EP in plasma were measured respective. Organ indexes of thymus, spleen, and uterus were calculated. The content of estrogen receptor (ER) in the hypothalamic, pituitary and uterus tissues and the content of androgen receptor (AR) in the hypothalamic homogenate were measured. The pathological changes of the thymus, spleen, uterus, ovary were observed by HE staining.
Compared with MC, PGC increase the activity, the organ index (thymus, spleen, uterus), E, T, BGP level in serum, β-EP level in plasma, AR level in hypothalamus, ER level in hypothalamus, pituitary, uterus in perimenopausal model rats. And it also reduced FSH, LH, GnRH level in serum, and improved uterine and ovarian lesions in perimenopausal model rats.
Each dose of PCG could counteract the disorder of sex hormone in perimenopausal model rats, correct the imbalance of ER and AR level, enhance and restore the effect of uterus and the nerve cells of hypothalamic, and improve immune function.
ETHNOPHARMACOLOGICAL 相关性:沙漠肉苁蓉草药最早记录在《神农本草经》中,并被列为其中的顶级草药。苯乙醇苷类化合物是中国药典中鉴定和含量测定沙漠肉苁蓉草药的指示性成分,也是其主要活性成分之一。在这项研究中,我们探讨了沙漠肉苁蓉草药苯乙醇苷对围绝经期模型大鼠的神经内分泌免疫功能的作用机制。
本研究旨在通过围绝经期模型大鼠研究沙漠肉苁蓉苯乙醇苷(PGC)对围绝经期综合征神经内分泌免疫功能的影响。
选择 Wistar 雌性大鼠。除空白对照组(BC)外,所有大鼠的左侧卵巢均被切除,右侧卵巢切除 80%。围绝经期模型大鼠的阴道涂片显示不规则的动情周期变化。给围绝经期模型大鼠灌胃更年安、沙漠肉苁蓉高、中、低悬液 450mg/(kg·天)、133.33mg/(kg·天)、66.67mg/(kg·天)、33.33mg/(kg·天);BC 组和模型组(MC)给予与药物组相同体积的蒸馏水,连续 30 天。在给药第 29 天测量水平-垂直运动评分。末次给药后,从腹主动脉采血,分别测定血清中 E、LH、FSH、GnRH、BGP 水平和血浆中 β-EP 水平。计算胸腺、脾、子宫器官指数。测定下丘脑、垂体和子宫组织中雌激素受体(ER)含量和下丘脑匀浆中雄激素受体(AR)含量。用 HE 染色观察胸腺、脾、子宫、卵巢的病理变化。
与 MC 相比,PGC 可提高围绝经期模型大鼠的活动度、器官指数(胸腺、脾、子宫)、血清 E、T、BGP 水平、血浆 β-EP 水平、下丘脑 AR 水平、下丘脑、垂体、子宫 ER 水平,同时降低血清 FSH、LH、GnRH 水平,改善围绝经期模型大鼠的子宫和卵巢病变。
PCG 各剂量均可拮抗围绝经期模型大鼠性激素紊乱,纠正 ER 和 AR 水平失衡,增强和恢复下丘脑神经细胞和子宫的作用,改善免疫功能。